Colin Kahrs Ph.D.

Colin Kahrs Ph.D.

Head of Intellectual Property at Asceneuron

Are you Colin Kahrs Ph.D.? Claim your profile
 
  • IDENTIFY executive and board member connections in Colin Kahrs Ph.D.'s network.
  • FOLLOW changes in Colin Kahrs Ph.D.'s employment.
  • CONNECT with Colin Kahrs Ph.D. through your network of contacts.

Colin Kahrs Ph.D.'s Executive Work History


Current
Head of Intellectual Property,
Head of Intellectual Property
Equilar on 10/20/2020
Asceneuron
Past
To view Colin Kahrs Ph.D.'s complete executive work history,
 

Colin Kahrs Ph.D.'s Biography


Colin Kahrs is the Head of Intellectual Property at Asceneuron.With over 20 years of experience in intellectual property for the pharmaceutical and chemical industry, Colin provides essential input to Asceneuron's strategy to protect its small molecule pipeline assets and supports the company in the management of its intellectual property portfolio.

Source: Asceneuron on 03/17/2020

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Colin Kahrs Ph.D.. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Colin Kahrs Ph.D.'s network.
  • FOLLOW changes in Colin Kahrs Ph.D.'s employment.
  • CONNECT with Colin Kahrs Ph.D. through your network of contacts.
 

Access over 2,000,000 executive and board member profiles.

Example: Colin Kahrs Ph.D.

Colin Kahrs Ph.D.'s Connections (16)


Bruno Permanne Ph.D.
Senior Director & Head of Preclinical Development, Asceneuron
Eric Yuen M.D.
Board Member, Asceneuron
Jeanne Elizabeth Bolger
Board Member, Life Healthcare Group Holdings Limited
Ryan Schubert M.D.
Senior Vice President Translational Medicine and Clinical Strategy, Asceneuron
Deborah Harland
Venture Partner, SR One
Vanessa Malier
Board Member, Step Pharma
Raymond G. Hill
Board Member, Addex Therapeutics Ltd
Anna Quattropani Ph.D.
Executive Vice President & Head of Non-Clinical Development and Medicinal Chemistry, Asceneuron
Dr. Ruhi Ahmed Ph.D.
Senior Vice President & Head of Regulatory Affairs, Asceneuron
Hakan Goker
Board Member, Artios Pharma